Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep356 | Thyroid | ECE2024

Intrathyroidal dexamethasone therapy in subacute thyroiditis: preliminary findings from the DLISAT Study

Stasiak Magdalena , Rosińska Magdalena , Berkan Zuzanna , Zygmunt Arkadiusz , Lewinski Andrzej

Background: Clinically severe or recurrent subacute thyroiditis (SAT) frequently requires treatment with high cumulative doses of systemic steroids. Such therapy is associated with high risk of steroid-related complications. The DLISAT study aims to evaluate the efficacy and safety of intrathyroidal dexamethasone and lidocaine injections (DLI) in specific patient cohorts compared to standard oral steroid therapy. This report presents preliminary results after the initial six m...

ea0032p1080 | Thyroid cancer | ECE2013

A single-center, open-label, phase II, proof-of-concept study with pasireotide long-acting release in patients with progressive medullary thyroid cancer: 6-month evaluation

Faggiano Antongiulio , Ferolla Piero , Vitale Giovanni , Del Prete Michela , Ramundo Valeria , Esposito Raffaella , Marotta Vincenzo , Marciello Francesca , Carratu Anna Chiara , Camera Luigi , Fonti Rosi , Colao Annamaria

Introduction: Medullary thyroid cancer (MTC) is a well-differentiated neuroendocrine tumor in which somatostatin receptor (sst) expression is higher for sst1 and sst5 than for sst2. This may explain why the available sst2–selective analogues do not work in these patients and why pasireotide (SOM230), a novel, multi-receptor targeted somatostatin analogue with high-binding affinity for sst1,2,3 and sst5 coul...